09.17.13
Boston, Mass.-based InspireMD Inc., maker of embolic protection stents, has named David Blossom its new vice president of global marketing and strategy.
Blossom, a 25-year sales and marketing veteran with expertise in interventional devices, will be responsible for creating and overseeing the implementation of a global strategic marketing plan. InspireMD has charged him with producing a comprehensive product portfolio plan that addresses the emerging coronary, carotid and multiple vascular opportunities available to the company.
“David’s significant experience in the interventional device market will be critically important to the Company as we move deeper into our coronary activities and begin executing on exciting new opportunities such as the carotid and peripheral applications of our technology,” commented Alan Milinazzo, CEO of InspireMD.
Prior to joining InspireMD, Blossom served as vice president of marketing for Aspect Medical Systems, which was acquired by Covidien in 2009, and Capella Medical Devices, which develops solutions for the treatment of complex coronary artery disease. At Covidien, he contributed to the company’s growth from a $20 million annual revenue business to $110 million.
Blossom also worked at Boston Scientific Corporation for eight years in senior marketing roles for the Vascular Division. During his tenure with Boston Scientific Vascular, he was responsible for the venous disease/vena cava filter product line, which ultimately became the top product in the market in that highly competitive product category.
Blossom holds a bachelor’s degree in journalism and advertising from Louisiana State University.
Blossom, a 25-year sales and marketing veteran with expertise in interventional devices, will be responsible for creating and overseeing the implementation of a global strategic marketing plan. InspireMD has charged him with producing a comprehensive product portfolio plan that addresses the emerging coronary, carotid and multiple vascular opportunities available to the company.
“David’s significant experience in the interventional device market will be critically important to the Company as we move deeper into our coronary activities and begin executing on exciting new opportunities such as the carotid and peripheral applications of our technology,” commented Alan Milinazzo, CEO of InspireMD.
Prior to joining InspireMD, Blossom served as vice president of marketing for Aspect Medical Systems, which was acquired by Covidien in 2009, and Capella Medical Devices, which develops solutions for the treatment of complex coronary artery disease. At Covidien, he contributed to the company’s growth from a $20 million annual revenue business to $110 million.
Blossom also worked at Boston Scientific Corporation for eight years in senior marketing roles for the Vascular Division. During his tenure with Boston Scientific Vascular, he was responsible for the venous disease/vena cava filter product line, which ultimately became the top product in the market in that highly competitive product category.
Blossom holds a bachelor’s degree in journalism and advertising from Louisiana State University.